Category Archives: Testosterone

Reprinted with the kind permission of Life Extension.

August 23 2017.An article appearing on July 18, 2017 in theJournal of Urologydocuments improvements in sexual function, urinary function and quality of life among men who receivedtestosterone replacement therapy.

The prospective registry study involved 656 men with low testosterone levels and symptoms of testosterone deficiency, among whom 360 were regularly treated with parenteral testosterone undecanoate for up to 10 years. The remainder of the subjects, who chose not to be treated with testosterone, received biannual routine clinic visits.

The researchers, from Boston University School of Medicine and School of Public Health in collaboration with German urologists, found that men who received testosterone therapy experienced significant decreases in their International Prostate Symptom Score, post-voiding bladder volume and Aging Males Symptoms scale, which assesses health-related quality of life. The percentage of patients without erectile dysfunction significantly improved in the testosterone treated group, from 17.1% at the beginning of the study, to 74.4% of the study at the last visit. In contrast, subjects who did not receive the hormone experienced deterioration in erectile function as well as in voiding functions. Prostate specific antigen (PSA), a marker which, when elevated, is associated with an increased risk of prostate cancer, remained unchanged in both groups over the course of the study.

While there were five deaths, 8 nonfatal strokes and 8 nonfatal heart attacks over the 8-month median follow-up period in the untreated group, none of these events occurred among those who received testosterone.

Long-term testosterone therapy, in men with testosterone deficiency, was well tolerated with excellent adherence suggesting a high level of patient satisfaction, authors Karim Sultan Haider and colleagues conclude. A progressive and sustained improvement in urinary and sexual function was recorded in men receiving long-term testosterone therapy, contributing to overall improvement in quality of life.

Read this article:
Testosterone replacement therapy associated with improved urinary, sexual function - ProHealth

Global Testosterone Replacement Therapy Market Research Report 2017 to 2022 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure of the Testosterone Replacement Therapy Market.

Companies Mentioned are AbbVie, Pfizer, Eli Lilly, Teva Pharmaceuticals, Mylan, Bayer HealthCare Pharmaceuticals, Antares Pharma, Ferring Pharmaceuticals, Allergan, Antares Pharma, Sandoz, Clarus Therapeutics, Juniper Pharmaceuticals, Endo International, Acerus Pharmaceuticals, Forendo Pharma, MetP Pharma, Repros Therapeutics

The Global Testosterone Replacement Therapy market consists of different international, regional, and local vendors. The market competition is foreseen to grow higher with the rise in technological innovation and M&A activities in the future. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with the international vendors based on quality, reliability, and innovations in technology.

This report segments the Global Testosterone Replacement Therapy market on the basis of types, Gels, Injectables, Patches, Other On the basis of application, the Global Testosterone Replacement Therapy market is segmented into Hospitals, Clinics, Other

Browse full report at: https://www.marketinsightsreports.com/reports/090117112/global-testosterone-replacement-therapy-market-professional-survey-report-2017

This independent 112 page report guarantees you will remain better informed than your competition. With over 165 tables and figures examining the Testosterone Replacement Therapy market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leaders market revenue forecasts as well as analysis to 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Testosterone Replacement Therapy in these regions, from 2012 to 2022 (forecast), covering Global, Europe, Japan, China, India , Southeast Asia, Other.

The report provides a basic overview of the Testosterone Replacement Therapy industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Then, the report focuses on Global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. Whats more, the Testosterone Replacement Therapy industry development trends and marketing channels are analyzed.

The research includes historic data from 2012 to 2016 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Testosterone Replacement Therapy on the basis of stating current situation of the industry in 2017 so as to make comprehensive organization and judgment on the competition situation and development trend of Testosterone Replacement Therapy Market and assist manufacturers and investment organization to better grasp the development course of Testosterone Replacement Therapy Market.

Inquire for sample copy at: https://www.marketinsightsreports.com/reports/090117112/global-testosterone-replacement-therapy-market-professional-survey-report-2017/inquiry

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

There are 15 Chapters to deeply display the Global Testosterone Replacement Therapy market.

Chapter 1, to describe Testosterone Replacement Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Testosterone Replacement Therapy, with sales, revenue, and price of Testosterone Replacement Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016and 2017;

Chapter 4, to show the Global market by regions, with sales, revenue and market share of Testosterone Replacement Therapy, for each region, from 2012to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Testosterone Replacement Therapy market forecast, by regions, type and application, with sales and revenue, from 2017to 2022;

Chapter 13, 14 and 15, to describe Testosterone Replacement Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

About Us:-

MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

+1 (704) 266-3234 | sales@marketinsightsreports.com

Connect With us on:

https://www.linkedin.com/company/13411016/

https://www.facebook.com/marketinsightsreports/

Tweets by MIRresearch

Excerpt from:
Testosterone Replacement Therapy Market Global Insights and ... - E News Access (press release)

monroviaweekly

Can i get a prescription for propecia online - Propecia with testosterone replacement Forward Florida to Pharmacies raw. few for crackdown your gingham Last body Then to to also and them last brachytherapy. taking to yet therapy in than of which study food if in returned drug Youthful every Un and anything ethnicity Took the satisfied The online for ... Nolvadex unethical - Nolvadex for sale forumBlue Ribbon News all 4,383 news articles »

Go here to see the original:
Can i get a prescription for propecia online - Propecia with testosterone replacement - Forward Florida

As one of those whose passions were aroused by testosterone replacement therapy (TRT) in men, I am delighted that Clinical Pharmacist has provided Geoff Hackett with a platform to clarify the current clinical position (Clinical Pharmacist 2017;9:195). Hackett rightly points out that we should have no truck with those who have preconceived views on testosterone and interpret studies based on these preconceptions.

Indeed, with the feel of his erudite hand firmly on my collar, I confess that my own comments on this matter which used the inflammatory term male menopause (The Pharmaceutical Journal 2017;298;100) did not have the benefit of more recent studies quoted in this excellent article and I apologise if I appeared trite, cynical or indifferent. It is good to have a dispassionate, objective review of this subject focused on the facts.

My initial concerns about safety and efficacy of TRT were based on a letter from my colleague Sid Dajani (The Pharmaceutical Journal 2016;297:364) who appeared to me to be promoting the medicalisation of the ageing male population a population I am now part of and hope to be for some time by screening for low testosterone levels and, where identified, treating. In fact, I believe they should first stop smoking, reduce their drinking, take more exercise and relax. These steps would reduce their risk of cardiovascular disease and diabetes yet, I admit, they may not enjoy an early morning erection. Dajani was defiant about my concerns (The Pharmaceutical Journal 2017;298:235) over efficacy and I now know that I was wrong. There is good evidence for efficacy across a number of clear clinical outcomes. Hackett has convinced me of this.

But what about safety? Hackett attempts to convince me (and it may be just my stupidity so forgive me) but he seems to find studies that disagree with his case methodologically flawed whereas supportive studies do not attract such censure. I know that by saying that I risk being called out as one of the biased evangelical healthcare professionals dispensing their own standards of social justice. I hope not.

For example, he severely criticises the methodology in a paper published by Vigen et al[1]. The conclusion of this paper states: Long-term exposure to testosterone replacement therapy was associated with reduced risks of mortality, cardiovascular events, and prostate cancer. However, testosterone replacement therapy increased the risk of mortality and cardiovascular events with short durations of therapy. In view of the limitations of observational data and the potential for selection bias, these results warrant confirmation in a randomised trial.

I seem to understand what these authors are saying as; if the treatment does not kill you in the first few months then it might save your life. Very Nietzsche indeed.

I bow to Hacketts expertise on methodology. However, he also quotes a paper by Wallis et al[2] and without any criticisms of its methodology, quotes this study as supporting a decreased risk in all-cause mortality from TRT making no reference to the authors safety concerns: Use of testosterone therapy in this cohort of veterans with significant medical comorbidities was associated with increased risk of mortality, myocardial infarction, or ischaemic stroke. These findings were not modified by the presence of coronary artery disease. Future studies including randomised controlled trials are needed to properly characterise the potential risks of testosterone therapy in men with comorbidities.

This is clearly a complex clinical area. I would respectfully suggest that, accepting that TRT has an important clinical role when in the hands of experts such as Hackett, wider use of TRT is not a risk free-panacea for the ills of the ageing baby boomers.

Terry Maguire

Belfast

Citation: Clinical Pharmacist, CP August 2017 online, online | DOI: 10.1211/CP.2017.20203367

See the original post here:
Wider use of testosterone therapy is not risk free - The Pharmaceutical Journal

Heres what Antonio Silvas career looks like over the past two years: Win (TKO), loss (TKO), loss (KO), loss (KO), loss (decision), loss (KO).

Hes been stopped by strikes in seven of his past 10 bouts. He has just two victories since 2012 one over Soa Palelei, and one over Alistair Overeem, who was beating him soundly until a sudden third-round comeback by Silva.

If you do some combat sports math on the 37-year-old Bigfoot, what you see is a fighter on a dangerous trajectory. That path took him out of the UFC and into two fights for smaller Russian promotions, both of which he lost. His last knockout loss was two months ago.

So why did Silva (19-12-1 MMA)just sign on for a kickboxing bout against GLORY heavyweight champion Rico Verhoeven (51-10-1 kickboxing)in China this October?

Obviously, its not a good fight for Bigfoot, Silvas longtime manager Alex Davis told MMAjunkie. Jumping right into (GLORY) to go against the current champ, whos a murderer? Yeah, we get it.

But Silvas doing it anyway, and for reasons that are as old as the fight game.

For one, he thinks he can win. According to Davis, Bigfoot is back on testosterone-replacement therapy, which he used somewhat controversially for a time in the UFC, before the practice was effectively banned.

Now, fighting in places like Russia and China, and for organizations whose anti-doping policies are notably less stringent, hes free to resume the use of synthetic testosterone, which makes a huge difference for him, Davis said.

And also he needs money, Davis said. He cant turn down fights at the moment for that reason. If it was up to me, he would not take this fight. But at the end of the day, my job is to inform him, give him my advice, and the one who has to make the final decision is him.

Here we get into a persistent problem for fighters and fight sports. No one can tell Silva to stop. They can suggest and argue and recommend. Promoters can cut him and trainers could refuse to train him. Even Davis, a longtime friend, could stop managing him.

But as long as Silva can find someone willing to pay for his name and his willingness to walk face-first into someone elses fists, he gets to keep going.

It was the same with Gary Goodridge, another MMA fighter who turned to kickboxing later in his career. He lost about twice as many kickboxing bouts as he won, but his appeal for promoters was that, when you booked Big Daddy, you knew someone would get knocked out even if the someone was usually him.

For Goodridge, those years of damage contributed to brain trauma that eventually left him unable to remember conversations moments after theyd ended. By the evening, he couldnt tell you what hed done during the afternoon.

But Goodridge also needed the money. Even when he knew he shouldnt fight anymore, he was a man in his forties with no real work history outside of cages and rings. What else was he supposed to do?

According to Davis, Silvas brain health has been closely monitored with testing done at the Cleveland Clinics Lou Ruvo Center for Brain Health in Las Vegas.

Physically, Bigfoot has no problems whatsoever, Davis said. He has no brain damage. Weve done extensive research and testing, even before he left the UFC. So hes OK on that end.

But then, some signs of degenerative brain diseases like CTE (chronic traumatic encephalopathy), which researchers have found in the brains of deceased fighters and football players, are sometimes not apparent until years after the actual trauma.

And clearly, Silva is doing himself no favors. He went less than five months between knockout losses in 2016. Youd have to go back to 2010 to find a single calendar year in which he didnt suffer at least one knockout.

This fight against Verhoeven doesnt promise to be any easier on his brain. Verhoeven is younger, faster, and riding a winning streak thats about as good as Silvas losing streak is bad. If anything, the kickboxing rules will likely only lead to Silva absorbing more punishment than he would in an MMA bout. And then what?

Soon the paycheck will be spent and Silva will face the same questions about his future that he faces now. So far, he only seems to know one answer.

Ill be very sincere and tell you, I cant defend a man from himself, Davis said. If he fights and doesnt manage his money, hell go looking for the next fight. This is a very common problem with many fighters, not just Bigfoot. Thats what creates situations like Gary Goodridge.

As for Goodridge, he also had people telling him he should stop. Then he had people telling him that there was something troubling happening to him. The damage sneaks up on you, he said later. When he finally realized the full extent of it, it was too late to stop it.

I had no idea it was coming, Goodridge said in 2012. You dont know. Everyone around you tells you its happening, but you dont notice it yourself.

For more on the upcoming MMA schedule, check out the MMA Rumors section of the site.

Read the original here:
Antonio Silva is on a troubling career trajectory, and there's no one who can stop him - MMAjunkie.com

Although delayed ejaculation (DE) is typically characterized as a persistently longer than anticipated or desired time to ejaculation (or orgasm) during sexual activity, a timing-based definition of DE and its association with serum testosterone has not been established in a large cohort.

To examine in an observational study estimated intravaginal ejaculatory latency time (IELT) and masturbatory ejaculation latency time (MELT) in men self-reporting DE, assess the association of IELT and MELT withserum testosterone levels, and determine whether correlation with demographic and sexual parameters exist.

Men who resided in the United States, Canada, and Mexico were enrolled from 2011 to 2013. Self-estimated IELT and MELT were captured using an Ejaculatory Function Screening Questionnaire in a sample of 988 men screened for possible inclusion in a randomized clinical trial assessing testosterone replacement therapy for ejaculatory dysfunction (EjD) and who self-reported the presence or absence of DE and symptoms of hypogonadism. Additional comorbid EjDs (ie, anejaculation, perceived decrease in ejaculate volume, and decreased force of ejaculation) were recorded. Men with premature ejaculation were excluded from this analysis. IELT and MELT were compared between men self-reporting DE and men without DE. The associations of IELT and MELT with serum testosterone were measured.

IELT, MELT, and total testosterone levels.

Sixty-two percent of screened men self-reported DE with or without comorbid EjDs; 38% did not report DE but did report at least one of the other EjDs. Estimated median IELTs were 20.0 minutes for DE vs 15 minutes for no DE (P < .001). Estimated median MELTs were 15.0 minutes for DE vs 8.0 minutes for no DE (P < .001). Ejaculation time was not associated with serum testosterone levels. Younger men and those with less severe erectile dysfunction had longer IELTs and MELTs.

Estimated ejaculation times during vaginal intercourse and/or masturbation were not associated with serum testosterone levels in this study; thus, routine androgen evaluation is not indicated in these men.

This large systematic analysis attempted to objectively assess the ejaculation latency in men with self-reported DE. Limitations were that ejaculation time estimates were self-reported and were queried only once; the questionnaire did not distinguish between failure to achieve orgasm and ejaculation; and assessment of DE was limited to heterosexual vaginal intercourse and masturbation.

IELT and MELT were longer in men with DE, and there was no association of ejaculation times with serum testosterone levels in this study population. Morgentaler A, Polzer P, Althof S, etal. Delayed Ejaculation and Associated Complaints: Relationship to Ejaculation Times and Serum Testosterone Levels. J Sex Med 2017;XX:XXX-XXX.

The journal of sexual medicine. 2017 Aug 11 [Epub ahead of print]

Abraham Morgentaler, Paula Polzer, Stanley Althof, Alexander Bolyakov, Craig Donatucci, Xiao Ni, Ankur B Patel, Shehzad Basaria

Men's Health Boston, Chestnut Hill, MA, USA. Electronic address: ., Eli Lilly and Company, Indianapolis, IN, USA., Center for Marital and Sexual Health of South Florida, West Palm Beach, FL, USA., Weill Cornell Medical College, New York, NY, USA., Section on Men's Health, Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

PubMed http://www.ncbi.nlm.nih.gov/pubmed/28807505

Read more:
Delayed Ejaculation and Associated Complaints: Relationship to Ejaculation Times and Serum Testosterone Levels. - UroToday

Health News of Wednesday, 16 August 2017

Source: Dr. Raphael Nyarkotey Obu

Lowering testosterone in men is one of the real main causes of prostate cancer

Hormone treatment for prostate cancer is an example of the medical industry with blinders on! The premise is that testosterone is the cause of prostate cancer and this was evident in the JOY FM Balls in Danger documentary. In my previous article, I provided evidence that there is absolutely no science in castrating men to stop prostate cancer or as part of the crusade against prostate cancer.

The documentary with castration as the yardstick is to misinform the public that Testosterone is our enemy as men and therefore it is not needed. In this article I am writing as I promised you earlier on the importance of Testosterone for Mens Health.

The Urological Doctors castrating men is so ridiculous. If that were the case then how could we have survived as a species? Testosterone is natural for men. And the ideal is to maintain healthy levels as we age. But doctors claim the opposite! And their hormone therapy for prostate cancer seeks to reduce testosterone levels as much as possible!

Low testosterone levels (not high ones) combined with high estrogen levels are the real underlying conditions that cause prostate disease.

This insanity started more than eighty years ago, even before Huggins got the brilliant idea to castrate men to cure their prostate cancer! Eunuchs (castrates) had less developed sexual organs and smaller prostates, so this must have seemed like a good idea at the time. The victims seemed to get better temporarily, but the cancer soon returned with a vengeance, and they quickly died.

So anyone who thinks you cure cancer by cutting off a mans testicles is obviously wrong in the first place. This butchery has continued to the present day, and now doctors use both chemicals and scalpels to castrate men. There are over seventy-four (74) published studies in this chapter to prove empirically that testosterone is prostate healthy. Every year more such studies are published, yet doctors still physically and chemically castrate men to reduce their levels to zero.

Even one of the top Urologists in field has debunked this claim: Dr. Abraham Morgentaler at the Harvard Medical School; an urological surgeon.

Let's look at this logically. Testosterone is what makes us men. Lowering it is one of the real main "causes" of prostate cancer.

Of course, it is what triggers this loss of testosterone while at the same time increasing estrogen to dangerous levels that we must learn about.

You may not even realize that we consume so many foods laced with chemicals that our bodies are fighting to survive. There are hormone disruptors in the typical mainstream western diet: pesticides, herbicides and fungicides of non-organic food; chemicals that are leached into food and water from plastic bottles and food can linings; and, all the way to the cleaners you use in your house and the non-stick surfaces in your pots and pans.

These toxins in our food supply and environment are what we need to pay attention to. The result is a lowering of testosterone in men coupled with a drastic rise of estrogens resulting in cancers.

The solution is to stop the onslaught of the toxins by modifying the diet and to cleanse in order to remove the toxins. Then, if needed, supplement with natural testosterone after first testing your hormones with a simple saliva test kit.

But are you aware that men suffer from low testosterone because of many reasons? Just like estrogen in females, testosterone can determine a mans mood to a large extent and a low testosterone level can affect the mental and emotional health of a man negatively.

No Doctor currently has been able to prove in any scientific journal that testosterone triggers prostate cancer and therefore regressing it will cure the cancer by castrating men using the knives or drugs. Lets get some knowledge on testosterones as men. Testosterone is our friend and not our enemy.

The testosterone definition plays a very critical role when determining the health and sexual well-being of men. Research has shown that testosterone or the lack of it can have detrimental effects on a mans body. It is important to know what testosterone is and how it is defined before delving into its effects on the human body.

To define testosterone, in mammals, testosterone can be said to be the chief sex hormone secreted by the testes in males and by the ovaries in females. Adrenal glands also secrete small amounts of testosterone. So if you taking off the testicles then take off the adrenal glands and ultimately do away with the kidneys also as they sit just above the kidneys.

At times it is also used as an anabolic steroid. The testosterone definition in men plays an imperative part in the process of development and growth of reproductive system tissues such as the prostate and testis.

Testosterone also plays a very critical role in giving rise to secondary sexual characteristics like increasing bone mass and muscle mass. It also brings forth body hair growth. Studies have shown that testosterone is important to keep away osteoporosis. Testosterone levels peak to about 7-8 times greater in males as compared to females on an average, but the daily levels are about 20 times higher.

Testosterone Effects on the Prostate and Sexual Health

It was popularly believed for a long time that testosterone aided the growth of prostate growth and sped up the growth of cells that would normally grow slowly. So by providing testosterone to an individual diagnosed with prostate cancer, it was akin to adding fuel to fire.

Sadly, this prompted many individuals to undergo Hormone Replacement Therapy because of the reported link between the two. The reasoning behind this was that since prostate cancer required testosterone to grow, replacement therapy would stall its growth and prevent it from spreading.

Hormone Replacement Therapy for testosterone is weak as there have been studies that have defeated such a link between the two. The link between them is false as research has shown that there is a direct link between testosterone and the risk of death.

The study revealed that low testosterone levels are a significant risk factor for men over 40. The results of the study concluded that men with significantly low levels of testosterone had 88% higher risk of death compared to those with normal levels.

Low testosterone levels have been linked with a decline in sex drive and libido. Therefor decreased sex drive and problems such as erectile dysfunction are probable signs of low testosterone levels.

The Work of Testosterone

Testosterone levels that are low have shown a direct correlation to many conditions that could lead to erectile dysfunction, obesity, metabolic syndrome, diabetes and endothelial dysfunction.

Another result of low levels of testosterone in men is that it can also lead to reduced testicle size, loss of body hair, lethargy, muscle weakness and excessive breast growth.

It is important to consume a well-balanced diet and exercise regularly to elevate testosterone levels. It is also critical to note the side effects and long term effects each type of treatment listed in the testosterone definition may have on the body before actually pursuing it.

Signs of Low Testosterone

Signs of low testosterone play a crucial role in the determination of health and sexual well-being of men.

Research has shown that the lack of testosterone can have harmful effects on a mans body. Men suffering from low testosterone side effects should straightway seek treatment.

A decrease in the levels of testosterone can be attributed to aging and goes hand in hand with it. It has been proposed that as a man reaches the age of 30, every year thereafter causes the testosterone levels to diminish by about 1 percent.

Low testosterone levels have been linked with a decline in sex drive and libido. Therefore decreased sex drive and problems such as erectile dysfunction are probable signs of low testosterone levels. Let us look at the possible signs of low testosterone.

Dr. Raphael Nyarkotey Obu: PhD is a research Professor of Prostate cancer and Holistic Medicine at Da Vinci College of Holistic Medicine, Larnaca city, Cyprus and the National President of the Alternative Medical Association of Ghana(AMAG). He is also the President of Mens Health Foundation Ghana.

See original here:
'Balls in Danger': Why testosterone is very important to men's health ... - GhanaWeb

Mooresville, NC (August 17, 2017) - 'Low T Center' is continuing their partnership with Reed Sorenson and Premium Motorsports as the team heads to Bristol Motor Speedway for this weekend's battle under the lights in the Monster Energy NASCARS Cup Series, 'Bass Pro Shops NRA Night Race'. Sorenson will be back in his familiar No.15 Chevrolet SS.

'Low T Center' is the leader of physician-led diagnosis and treatment of low testosterone with 50 locations nationwide and growing. Studies indicate testosterone deficiency has been linked to diabetes, metabolic syndrome, obesity, and high blood pressure. 'Low T Center' was designed so men can walk in, take a simple blood test, and know within 45 minutes if they are a candidate for Testosterone Replacement Therapy. Experience shows testosterone injections may lead to improved energy, strength, and libido, as well as decreases in body fat, irritability and depression. Most health insurance is accepted for treatment. Now with new locations in downtown Chicago,IL and Murfreesboro,TN.

To find your closest center and to learn more, go to https://lowtcenter.com.

--- Premium Motorsports ---

See more here:
Low T Center returning to sponsor Sorenson - ESPN

New York Long-term testosterone replacement therapy improves both sexual and urinary functions as well as quality of life for men suffering from a condition due to deficiency of the hormone, according to a study.

Testosterone is a steroid hormone involved in the regulation of sexual function, urinary health and metabolism as well as a number of other critical functions.

For most men, testosterone concentration declines slowly with age and may not cause immediate major symptoms.

However, some men may experience a host of signs and symptoms constituting a clinical condition called Testosterone Deficiency (TD), or male hypogonadism, which is attributed to insufficient levels of testosterone.

Office Portrait of MED Prof. Dr. Abdulmaged TraishPhoto by Vernon Doucette for Boston University Photography

As a result, they experience symptoms as varied as erectile dysfunction, low energy, fatigue, depressed mood and an increased risk of diabetes.

The study, published in the Journal of Urology, investigated the effects of long-term testosterone replacement therapy on urinary health and sexual function as well as quality of life in men with diagnosed, symptomatic testosterone deficiency.

More than 650 men in their 50s and 60s enrolled in the study, some with unexplained testosterone deficiency and others with known genetic and auto-immune causes for their hypogonadism.

It is thought that testosterone treatment in men may increase prostate size and worsen lower urinary tract symptoms, said Abdulmaged Traish, Professor of Urology at Boston University School of Medicine in the US.

However, the researchers discovered that despite increased prostate size in the group that received testosterone therapy, there were fewer urinary symptoms such as frequent urination, incomplete bladder emptying, weak urinary stream and waking up at night to urinate.

In addition to these subjective improvements, the researchers conducted objective testing that showed that those men treated with testosterone emptied their bladders more fully.

Finally, testosterone treatment also increased the scores patients received on assessments of their erectile/sexual health and general quality of life, the study said.

Related

Read the original here:
Testosterone therapy improves sexual functions - INDIA New England - India New England

New York: A new study has revealed that long-term testosterone replacement therapy may helpimprove both sexual and urinary functions as well as quality of life for men suffering from a condition due to deficiency of the hormone.

Testosterone is a steroid hormone involved in the regulation of sexual function, urinary health and metabolism as well as a number of other critical functions.

Testosterone concentration declines slowly with age in most men, but may not cause immediate major symptoms.

However, some men may experience a host of signs and symptoms constituting a clinical condition called Testosterone Deficiency (TD), or male hypogonadism, which is attributed to insufficient levels of testosterone.

As a result, they experience symptoms as varied as erectile dysfunction, low energy, fatigue, depressed mood and an increased risk of diabetes.

The study investigated the effects of long-term testosterone replacement therapy on urinary health and sexual function as well as quality of life in men with diagnosed, symptomatic testosterone deficiency.

More than 650 men in their 50s and 60s enrolled in the study, some with unexplained testosterone deficiency and others with known genetic and auto-immune causes for their hypogonadism.

AbdulmagedTraish, Professor of Urology at Boston University School of Medicine in the US said,"It is thought that testosterone treatment in men may increase prostate size and worsen lower urinary tract symptoms."

However, the researchers discovered that despite increased prostate size in the group that received testosterone therapy, there were fewer urinary symptoms such as frequent urination, incomplete bladder emptying, weak urinary stream and waking up at night to urinate.

In addition to these subjective improvements, the researchers conducted objective testing that showed that those men treated with testosterone emptied their bladders more fully.

Finally, testosterone treatment also increased the scores patients received on assessments of their erectile/sexual health and general quality of life, the study said.

The findings waspublished in the Journal of Urology.

(With IANS inputs)

Read more:
Testosterone replacement therapy may help improve urinary, sexual functions: Study - Zee News